{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T07:09:27Z","timestamp":1771744167180,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007701","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000}}],"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R00HL138272"],"award-info":[{"award-number":["R00HL138272"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61873080"],"award-info":[{"award-number":["61873080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007701","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T18:35:34Z","timestamp":1582742134000},"page":"e1007701","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes"],"prefix":"10.1371","volume":"16","author":[{"given":"Chuang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9864-205X","authenticated-orcid":true,"given":"Jennifer","family":"Hockings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-6415","authenticated-orcid":true,"given":"Ruth","family":"Nussinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charis","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1736-2847","authenticated-orcid":true,"given":"Feixiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"issue":"6127","key":"pcbi.1007701.ref001","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"B Vogelstein","year":"2013","journal-title":"Science"},{"issue":"6255","key":"pcbi.1007701.ref002","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.aab4082","article-title":"Somatic mutation in cancer and normal cells","volume":"349","author":"I Martincorena","year":"2015","journal-title":"Science"},{"issue":"1","key":"pcbi.1007701.ref003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2013.03.002","article-title":"Lessons from the cancer genome","volume":"153","author":"LA Garraway","year":"2013","journal-title":"Cell"},{"issue":"2","key":"pcbi.1007701.ref004","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"MH Bailey","year":"2018","journal-title":"Cell"},{"issue":"2","key":"pcbi.1007701.ref005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrd.2017.14","article-title":"FDA drug approvals","volume":"16","author":"A. Mullard","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"pcbi.1007701.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.118.016253","article-title":"Personal mutanomes meet modern oncology drug discovery and precision health","volume":"71","author":"F Cheng","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"4","key":"pcbi.1007701.ref007","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.09.057","article-title":"Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors","volume":"155","author":"BM Emerling","year":"2013","journal-title":"Cell"},{"issue":"5","key":"pcbi.1007701.ref008","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cell.2017.01.013","article-title":"Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic Ras","volume":"168","author":"T Wang","year":"2017","journal-title":"Cell"},{"issue":"10","key":"pcbi.1007701.ref009","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrg.2017.47","article-title":"Synthetic lethality and cancer","volume":"18","author":"NJ O'Neil","year":"2017","journal-title":"Nat Rev Genet"},{"issue":"18","key":"pcbi.1007701.ref010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJMra1407390","article-title":"Applying synthetic lethality for the selective targeting of cancer","volume":"371","author":"DP McLornan","year":"2014","journal-title":"N Engl J Med"},{"key":"pcbi.1007701.ref011","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharmthera.2016.01.014","article-title":"Synthetic lethal approaches for assessing combinatorial efficacy of chemotherapeutic drugs","volume":"162","author":"RA Jackson","year":"2016","journal-title":"Pharmacol Ther"},{"key":"pcbi.1007701.ref012","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1038\/s41467-019-10744-6","article-title":"A genome-wide positioning systems network algorithm for in silico drug repurposing","volume":"10","author":"F Cheng","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"pcbi.1007701.ref013","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/molbev\/msy085","article-title":"Neutral theory, disease mutations, and personal exomes","volume":"35","author":"S Kumar","year":"2018","journal-title":"Mol Biol Evol"},{"key":"pcbi.1007701.ref014","article-title":"Computational network biology: Data, models, and applications","author":"C Liu","year":"2020","journal-title":"Phys Rep"},{"issue":"8","key":"pcbi.1007701.ref015","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-16-0178","article-title":"CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions","volume":"6","author":"DM Munoz","year":"2016","journal-title":"Cancer Discov"},{"issue":"12","key":"pcbi.1007701.ref016","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"RM Meyers","year":"2017","journal-title":"Nat Genet"},{"issue":"5","key":"pcbi.1007701.ref017","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.cell.2014.07.027","article-title":"Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality","volume":"158","author":"L Jerby-Arnon","year":"2014","journal-title":"Cell"},{"key":"pcbi.1007701.ref018","doi-asserted-by":"crossref","first-page":"15580","DOI":"10.1038\/ncomms15580","article-title":"Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data","volume":"8","author":"S Sinha","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"pcbi.1007701.ref019","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1101\/gr.125567.111","article-title":"Mutual exclusivity analysis identifies oncogenic network modules","volume":"22","author":"G Ciriello","year":"2012","journal-title":"Genome Res"},{"issue":"6","key":"pcbi.1007701.ref020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/bioinformatics\/btw242","article-title":"WeSME: uncovering mutual exclusivity of cancer drivers and beyond","volume":"33","author":"YA Kim","year":"2017","journal-title":"Bioinformatics"},{"issue":"8","key":"pcbi.1007701.ref021","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/molbev\/msu167","article-title":"Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome","volume":"31","author":"F Cheng","year":"2014","journal-title":"Mol Biol Evol"},{"issue":"9","key":"pcbi.1007701.ref022","doi-asserted-by":"crossref","first-page":"e1004497","DOI":"10.1371\/journal.pcbi.1004497","article-title":"A gene gravity model for the evolution of cancer genomes: A study of 3,000 cancer genomes across 9 cancer types","volume":"11","author":"F Cheng","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"pcbi.1007701.ref023","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"N. Cancer Genome Atlas","year":"2015","journal-title":"Cell"},{"issue":"7418","key":"pcbi.1007701.ref024","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"N. Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"issue":"11","key":"pcbi.1007701.ref025","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1021\/acs.chemrev.5b00542","article-title":"Ras conformational ensembles, allostery, and signaling","volume":"116","author":"S Lu","year":"2016","journal-title":"Chem Rev"},{"issue":"2","key":"pcbi.1007701.ref026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12032-016-0879-9","article-title":"KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma","volume":"34","author":"J Cicenas","year":"2017","journal-title":"Med Oncol"},{"issue":"2","key":"pcbi.1007701.ref027","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1593\/neo.101088","article-title":"Identification of H-Ras-specific motif for the activation of invasive signaling program in human breast epithelial cells","volume":"13","author":"HY Yong","year":"2011","journal-title":"Neoplasia"},{"issue":"3","key":"pcbi.1007701.ref028","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/path.2983","article-title":"BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain","volume":"226","author":"AH Sillars-Hardebol","year":"2012","journal-title":"J Pathol"},{"issue":"4","key":"pcbi.1007701.ref029","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.cdd.4400662","article-title":"Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance","volume":"7","author":"Y Fernandez","year":"2000","journal-title":"Cell Death Differ"},{"issue":"3","key":"pcbi.1007701.ref030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"CFA Warren","year":"2019","journal-title":"Cell Death Dis"},{"issue":"5","key":"pcbi.1007701.ref031","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1158\/0008-5472.CAN-12-2929","article-title":"Targeting XRCC1 deficiency in breast cancer for personalized therapy","volume":"73","author":"R Sultana","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"pcbi.1007701.ref032","first-page":"217","article-title":"Polymorphisms in the DNA repair gene XRCC1 and breast cancer","volume":"10","author":"EJ Duell","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"pcbi.1007701.ref033","first-page":"928787","article-title":"Long term progression-free survival in a patient with locally advanced prostate cancer under low dose intermittent androgen deprivation therapy with bicalutamide only","volume":"2015","author":"S Latz","year":"2015","journal-title":"Case Rep Urol"},{"issue":"1","key":"pcbi.1007701.ref034","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1211\/0022357055164","article-title":"Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines","volume":"57","author":"J Bouchal","year":"2005","journal-title":"J Pharm Pharmacol"},{"issue":"18","key":"pcbi.1007701.ref035","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1158\/0008-5472.CAN-12-0228","article-title":"Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer","volume":"72","author":"H Cai","year":"2012","journal-title":"Cancer Res"},{"issue":"12","key":"pcbi.1007701.ref036","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","article-title":"Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations","volume":"7","author":"JD Fackenthal","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"pcbi.1007701.ref037","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/modpathol.2011.211","article-title":"BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma","volume":"25","author":"JN McAlpine","year":"2012","journal-title":"Mod Pathol"},{"issue":"10","key":"pcbi.1007701.ref038","first-page":"4092","article-title":"TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution","volume":"61","author":"MS Greenblatt","year":"2001","journal-title":"Cancer Res"},{"issue":"4","key":"pcbi.1007701.ref039","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","article-title":"Antiangiogenic therapy: impact on invasion, disease progression, and metastasis","volume":"8","author":"JM Ebos","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"pcbi.1007701.ref040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10549-012-2003-y","article-title":"A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab","volume":"133","author":"NU Lin","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"pcbi.1007701.ref041","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/onc.2016.184","article-title":"The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer","volume":"36","author":"LL da Motta","year":"2017","journal-title":"Oncogene"},{"issue":"9","key":"pcbi.1007701.ref042","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/1078-0432.CCR-16-0966","article-title":"Impact of TP53 mutations on outcome in EGFR-mutated patients treated with first-line tyrosine kinase inhibitors","volume":"23","author":"M Canale","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"12","key":"pcbi.1007701.ref043","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.celrep.2017.11.095","article-title":"BET bromodomain inhibition synergizes with PARP inhibitor in epithelial ovarian cancer","volume":"21","author":"S Karakashev","year":"2017","journal-title":"Cell Rep"},{"issue":"6","key":"pcbi.1007701.ref044","doi-asserted-by":"crossref","first-page":"e000093","DOI":"10.1136\/esmoopen-2016-000093","article-title":"Specific CDK4\/6 inhibition in breast cancer: a systematic review of current clinical evidence","volume":"1","author":"A Polk","year":"2016","journal-title":"ESMO Open"},{"issue":"1","key":"pcbi.1007701.ref045","first-page":"13","article-title":"miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer","volume":"39","author":"S Tatarano","year":"2011","journal-title":"Int J Oncol"},{"issue":"23","key":"pcbi.1007701.ref046","doi-asserted-by":"crossref","first-page":"20774","DOI":"10.1074\/jbc.M101324200","article-title":"Phosphorylation of centrin during the cell cycle and its role in centriole separation preceding centrosome duplication","volume":"276","author":"W Lutz","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"pcbi.1007701.ref047","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2402454","article-title":"Centrosome replication, genomic instability and cancer","volume":"16","author":"A Kramer","year":"2002","journal-title":"Leukemia"},{"issue":"7","key":"pcbi.1007701.ref048","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/1078-0432.CCR-14-2522","article-title":"FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma","volume":"21","author":"BW Miller","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"2","key":"pcbi.1007701.ref049","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.celrep.2013.12.035","article-title":"Assessing PIK3CA and PTEN in early-phase trials with PI3K\/AKT\/mTOR inhibitors","volume":"6","author":"F Janku","year":"2014","journal-title":"Cell Rep"},{"issue":"6306","key":"pcbi.1007701.ref050","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1420","article-title":"A global genetic interaction network maps a wiring diagram of cellular function","volume":"353","author":"M Costanzo","year":"2016","journal-title":"Science"},{"issue":"1","key":"pcbi.1007701.ref051","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tig.2005.10.002","article-title":"Causes of oncogenic chromosomal translocation","volume":"22","author":"PD Aplan","year":"2006","journal-title":"Trends Genet"},{"issue":"2","key":"pcbi.1007701.ref052","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cell.2018.03.027","article-title":"A pan-cancer analysis of enhancer expression in nearly 9000 patient samples","volume":"173","author":"H Chen","year":"2018","journal-title":"Cell"},{"issue":"7291","key":"pcbi.1007701.ref053","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature08987","article-title":"International network of cancer genome projects","volume":"464","author":"C International Cancer Genome","year":"2010","journal-title":"Nature"},{"issue":"37","key":"pcbi.1007701.ref054","doi-asserted-by":"crossref","first-page":"E5189","DOI":"10.1073\/pnas.1511585112","article-title":"Comparison of predicted and actual consequences of missense mutations","volume":"112","author":"LA Miosge","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pcbi.1007701.ref055","article-title":"A Landscape of Pharmacogenomic Interactions in Cancer","author":"F Iorio","year":"2016","journal-title":"Cell"},{"key":"pcbi.1007701.ref056","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","author":"Y Benjamini","year":"1995","journal-title":"J R Statist S (Methodological)"},{"issue":"D1","key":"pcbi.1007701.ref057","doi-asserted-by":"crossref","first-page":"D1011","DOI":"10.1093\/nar\/gkv1108","article-title":"SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets","volume":"44","author":"J Guo","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pcbi.1007701.ref058","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nmeth.4225","article-title":"Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions","volume":"14","author":"JP Shen","year":"2017","journal-title":"Nat Methods"},{"issue":"3","key":"pcbi.1007701.ref059","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.molcel.2016.06.022","article-title":"A network of conserved synthetic lethal interactions for exploration of precision cancer therapy","volume":"63","author":"R Srivas","year":"2016","journal-title":"Mol Cell"},{"issue":"D1","key":"pcbi.1007701.ref060","doi-asserted-by":"crossref","first-page":"D807","DOI":"10.1093\/nar\/gky1053","article-title":"OrthoDB v10: sampling the diversity of animal, plant, fungal, protist, bacterial and viral genomes for evolutionary and functional annotations of orthologs","volume":"47","author":"EV Kriventseva","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pcbi.1007701.ref061","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nmeth.2956","article-title":"TCGA-assembler: open-source software for retrieving and processing TCGA data","volume":"11","author":"Y Zhu","year":"2014","journal-title":"Nat Methods"},{"key":"pcbi.1007701.ref062","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"11","author":"SA Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"pcbi.1007701.ref063","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes","volume":"4","author":"PA Futreal","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"pcbi.1007701.ref064","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jamia\/ocw007","article-title":"A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes","volume":"23","author":"F Cheng","year":"2016","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"pcbi.1007701.ref065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc.2015.4","article-title":"DNA repair, genome stability and cancer: a historical perspective","volume":"16","author":"PA Jeggo","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"pcbi.1007701.ref066","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas","volume":"23","author":"TA Knijnenburg","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"pcbi.1007701.ref067","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrg3345","article-title":"Chromatin and the genome integrity network","volume":"14","author":"M Papamichos-Chronakis","year":"2013","journal-title":"Nat Rev Genet"},{"issue":"7753","key":"pcbi.1007701.ref068","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","volume":"568","author":"FM Behan","year":"2019","journal-title":"Nature"},{"issue":"8","key":"pcbi.1007701.ref069","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"G Bindea","year":"2009","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007701","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T18:09:11Z","timestamp":1695838151000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007701"}},"subtitle":[],"editor":[{"given":"Qing","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007701","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1007701","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]}}}